PROBIOTIX HEALTH LS-05 (F:X90) — Stock Price
PROBIOTIX HEALTH LS-05 (F:X90) is currently trading at €0.08 EUR, up 15.22% today. Over the past 52 weeks, shares have ranged between €0.05 and €0.08. This page tracks PROBIOTIX HEALTH LS-05's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see PROBIOTIX HEALTH LS-05 market capitalisation.
PROBIOTIX HEALTH LS-05 (X90) Stock Price Chart — Daily History & Trading Volume
The chart below tracks PROBIOTIX HEALTH LS-05's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
PROBIOTIX HEALTH LS-05 Income Statement — Revenue, Profit & Earnings by Year
PROBIOTIX HEALTH LS-05's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 |
|---|---|---|
| Total Revenue | €1.88 Million | €1.67 Million |
| Cost of Revenue | €886.00K | €801.00K |
| Gross Profit | €997.00K | €872.00K |
| Research & Development | €28.00K | €31.00K |
| SG&A | €838.00K | €727.00K |
| Total Operating Expenses | €2.72 Million | €2.39 Million |
| Operating Income | €-839.00K | €-719.00K |
| EBITDA | — | — |
| EBIT | — | — |
| Interest Expense | — | — |
| Income Before Tax | €-852.00K | €-762.00K |
| Income Tax Expense | — | — |
| Net Income | €-847.00K | €-747.00K |
PROBIOTIX HEALTH LS-05 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes PROBIOTIX HEALTH LS-05's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | €2.18 Million | €2.17 Million | €2.34 Million |
| Total Current Assets | €1.93 Million | €1.87 Million | €2.02 Million |
| Cash & Equivalents | — | — | — |
| Short-term Investments | — | — | — |
| Net Receivables | €141.00K | €203.00K | €351.79K |
| Inventory | €31.00K | €103.00K | €43.42K |
| Property, Plant & Equipment | — | — | — |
| Goodwill | — | — | — |
| Total Liabilities | €254.00K | €641.00K | €350.91K |
| Total Current Liabilities | €194.00K | €566.00K | €272.04K |
| Long-term Debt | — | — | — |
| Net Debt | — | — | — |
| Total Stockholder Equity | €1.92 Million | €1.53 Million | €1.99 Million |
| Retained Earnings | €-1.79 Million | €-980.00K | €-190.52K |
PROBIOTIX HEALTH LS-05 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how PROBIOTIX HEALTH LS-05 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating Cash Flow | €-1.06 Million | €-238.00K | €-638.02K |
| Capital Expenditures | €10.00K | €0.00 | €46.08K |
| Free Cash Flow | €-1.07 Million | €-238.00K | €-684.09K |
| Investing Cash Flow | — | — | — |
| Financing Cash Flow | — | — | — |
| Dividends Paid | — | — | — |
| Stock-Based Compensation | €26.00K | €33.00K | — |
| Depreciation | €53.00K | €53.00K | €32.79K |
| Change in Cash | €144.00K | €-238.00K | €1.54 Million |
PROBIOTIX HEALTH LS-05 Earnings History — EPS Actual vs. Analyst Estimates
Track PROBIOTIX HEALTH LS-05's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 08, 2025 | 0.00 | 0.00 | — |
| May 29, 2025 | 0.00 | 0.00 | — |
| Aug 30, 2024 | 0.00 | 0.00 | — |